Bharat Immunologicals & Biologicals share news and announcements

BSE: 524663Pharmaceuticals & BiotechnologySmall Cap

₹9.27₹0.09 (0.98%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹9.18.

52-week range of traded prices to 23 Oct 2026

₹7.11Low, 6 Oct 2026₹22.61High, 23 Dec 2025

Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: Share count not known3,103rd largest listed
P/E: Share count not known
P/B: Share count not known
Dividend yield: –
Volume, BSE: 28,767

Last results date

The last board meeting held for results; the company has not yet given notice of the next.Bharat Immunologicals & Biologicals quarterly results

Oct31Tue

The board met on 31 Oct 2023 to consider quarterly results

Notice filed 19 Oct 2023

Bharat Immunologicals & Biologicals annual reports, presentations and earnings calls

The company's own documents, latest first.Bharat Immunologicals & Biologicals financials, year by year

Annual reports25

Annual report, 2022 (opens in a new tab)23 Sep 2022
Annual report, 2021 (opens in a new tab)8 Nov 2021
Annual report, 2020 (opens in a new tab)29 Dec 2020
Annual report, year to Mar 2019 (opens in a new tab)27 Sep 2019
Annual report, year to Mar 2018 (opens in a new tab)29 Aug 2018

20 earlier reports

Annual report, year to Mar 2017 (opens in a new tab)4 Oct 2017
Annual report, year to Mar 2016 (opens in a new tab)30 Sep 2016
Annual report, year to Mar 2015 (opens in a new tab)7 Sep 2015
Annual report, year to Mar 2014 (opens in a new tab)Filing day not known
Annual report, year to Mar 2013 (opens in a new tab)16 Sep 2013
Annual report, year to Mar 2012 (opens in a new tab)4 Dec 2012
Annual report, year to Mar 2011 (opens in a new tab)15 Dec 2011
Annual report, year to Mar 2010 (opens in a new tab)Filing day not known
Annual report, year to Mar 2009 (opens in a new tab)Filing day not known
Annual report, year to Mar 2008 (opens in a new tab)Filing day not known
Annual report, year to Mar 2007 (opens in a new tab)Filing day not known
Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
Annual report, year to Mar 2004 (opens in a new tab)Filing day not known
Annual report, year to Mar 2003 (opens in a new tab)Filing day not known
Annual report, year to Mar 2002 (opens in a new tab)Filing day not known
Annual report, year to Mar 2000 (opens in a new tab)Filing day not known
Annual report, year to Mar 1999 (opens in a new tab)Filing day not known
Annual report, year to Mar 1998 (opens in a new tab)Filing day not known
Annual report, year to Mar 1997 (opens in a new tab)Filing day not known

Bharat Immunologicals & Biologicals share news and announcements

263 announcements, routine notices left out, newest first. Page 1 of 6.

Sep 2026
- 30 Sep · Legal
  Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on September 30, 2026 with reference to significant movement in price, in order to ensure ....
- 17 Sep · Announcement under Regulation 30 (LODR)-Winding-up
  (s) of SEBI LODR, It is informed that the Government of India has approved the closure of Bharat Immunologicals and Biologicals .... (opens in a new tab)
Aug 2024
- 7 Aug · Board meeting
  Meeting on 16 Aug 2024
- 7 Aug · Board meeting
  BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 ,inter alia, to consider and approve .... (opens in a new tab)
Feb 2024
- 29 Feb · Board meeting
  Meeting on 8 Mar 2024
- 29 Feb · Board meeting
  BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 ,inter alia, to consider and approve .... (opens in a new tab)
Dec 2023
- 13 Dec · Meeting
  Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023 (opens in a new tab)
Nov 2023
- 28 Nov · Meeting
  Intimation of Book Closure in respect of AGM (opens in a new tab)
- 28 Nov · Meeting
  Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023. Submitted for kind information and record please. (opens in a new tab)
- 1 Nov · Results
  Submission of UAFR alongwith Limited Review Report for the quarter and half year ended September 2023 (opens in a new tab)
- 1 Nov · Results
  Submission of UAFR June 2023 (opens in a new tab)
Oct 2023
- 19 Oct · Board meeting
  Meeting on 31 Oct 2023: quarterly results
- 19 Oct · Board meeting
  BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 ,inter alia, to consider and approve .... (opens in a new tab)
Sep 2023
- 15 Sep · Management
  As captioned subject (opens in a new tab)
May 2023
- 31 May · Management
  Annual Accounts i.e. the Balance Sheet and Statement of Profit & Loss account approved by Board in its meeting held on 24.04.2023 and provided to Statutory Auditors for the year ended .... (opens in a new tab)
- 10 May · Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ending On 31.03.2023.
  It is submitted the Certificate duly signed by M/s MAS Services Ltd, Share Transfer .... (opens in a new tab)
Apr 2023
- 27 Apr · Certificate From Practicing Company Secretary Under Regulation 40 (9) Of SEBI (LODR) Regulations 2015 For The Year Ended 31.03.2023
  In pursuance of Regulation 40 (9) of the LODR with Stock Exchange, please find attached the Certificate from Practicing Company Secretary for the year ended 31st March 2023. (opens in a new tab)
- 17 Apr · Board meeting
  Meeting on 24 Apr 2023: audited results
- 17 Apr · Board meeting
  Board Meeting to be held on 24/04/2023 has been revised to 24/04/2023 The Board Meeting to be held on 24/04/2023 has been revised to 24/04/2023 (opens in a new tab)
- 17 Apr · Board meeting
  BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2023 ,inter alia, to consider and approve .... (opens in a new tab)
Feb 2023
- 10 Feb · Results
  In compliance of SEBI LODR with Stock Exchange, please find enclosed the Unaudited Quarterly Financial Results for the quarter and nine months ended December 2022 along with Limited Review .... (opens in a new tab)
- 1 Feb · Board meeting
  Meeting on 9 Feb 2023: quarterly results
- 1 Feb · Board meeting
  BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve .... (opens in a new tab)
Dec 2022
- 27 Dec · Legal
  Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on December 27, 2022, with reference to Movement in Price. The reply is awaited.
Oct 2022
- 17 Oct · Board meeting
  In pursuance of the SEBI LODR, please find attached the Un-audited Quarterly Financial Results for the quarter ended September 2022 and Limited Review Report thereon as per the Compliance of LODR 2015 (opens in a new tab)
- 11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 6 Oct · Board meeting
  Meeting on 17 Oct 2022: quarterly results
- 6 Oct · Board meeting
  BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2022 ,inter alia, to consider and approve .... (opens in a new tab)
Sep 2022
- 29 Sep · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI LODR 2015 For The Year 2021-22.
  In pursuance of compliance of Regulation 7(3) of SEBI's LODR 2015 with Stock Exchange, please find attached herewith a certificate, duly signed by Mas Services Limited, RTA and the Company .... (opens in a new tab)
- 23 Sep · Reg. 34 (1) Annual Report.
  Annual General Meeting of the Shareholder of the company is scheduled on 30.09.2022, and the Annual Report to be placed at Shareholders meeting for consideration is submitted at BSE please. (opens in a new tab)
- 6 Sep · Meeting
  In compliance with the provision of LODR, 2015, it is intimated that, for the financial year 2021-22, the 33rd Annual General Meeting of the Company is Scheduled to be held on 30th September .... (opens in a new tab)
- 6 Sep · Meeting
  In pursuance of the provision of LODR 2015, please find attached herewith the Notice of 33rd Annual General Meeting of the Company on 30.09.2022 for the financial year 2021-22. The Notice .... (opens in a new tab)
Aug 2022
- 15 Aug · Board meeting
  In pursuance of the SEBI LODR, please find attached the Un-audited Quarterly Financial Results for the quarter ended June 2022 and Limited Review Report thereon as per the Compliance of LODR 2015. (opens in a new tab)
- 3 Aug · Board meeting
  Meeting on 11 Aug 2022: quarterly results
- 3 Aug · Board meeting
  BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 ,inter alia, to consider and approve .... (opens in a new tab)
Jun 2022
- 15 Jun · Certificate From Practicing Company Secretary Under Regulation 40 (9) Of SEBI (LODR) Regulations 2015 For The Year Ended 31.03.2022
  In pursuance of Regulation 40 (9) of the LODR with Stock Exchange, please find attached the Certificate from Practicing Company Secretary for the year ended 31st March 2022. It is requested .... (opens in a new tab)
May 2022
- 31 May · Results
  In compliance of SEBI LODR with Stock Exchange, please find enclosed the Reviewed Annual Financial Results for the year ended 31st March 2022. (opens in a new tab)
- 18 May · Board meeting
  Meeting on 30 May 2022: audited results and quarterly results
- 18 May · Board meeting
  BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve .... (opens in a new tab)
Apr 2022
- 8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2022
- 9 Feb · Results
  In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 31st December 2021. .... (opens in a new tab)
- 9 Feb · Board meeting
  In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended December 2021 approved by the Board of the Company in .... (opens in a new tab)
Jan 2022
- 31 Jan · Board meeting
  Meeting on 8 Feb 2022: quarterly results
- 31 Jan · Board meeting
  BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 ,inter alia, to consider and approve .... (opens in a new tab)
- 31 Jan · Shareholding for the Period Ended December 31, 2021
  Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....
- 10 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2021
- 1 Dec · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Nov 2021
- 15 Nov · Results
  In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 30th September 2021. .... (opens in a new tab)
- 15 Nov · Results
  In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 30th September 2021. (opens in a new tab)
- 8 Nov · Reg. 34 (1) Annual Report
  Annual General Meeting of the Shareholder of the company is scheduled on 30.11.2021, and the Annual Report to be placed at Shareholders meeting for consideration is submitted at BSE .... (opens in a new tab)

How the price met the news

The first session after each announcement, beside the market.

That dayAgainst the Nifty 500Market median on that newsFive sessionsFive sessions against the Nifty 500Volume, times usual

27 Sep 2019Dividenddown 3.15%−2.6 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−2.0 pts vs Nifty 500) · volume 1.1× usual · The announcement (opens in a new tab)
5 Sep 2019Dividendup 3.63%+3.5 pts vs Nifty 500market median 0.0% · five sessions +13.0% (+11.4 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)

Sharp moves

The latest 30. 26 of the 30 shown had no filing that day or the next.

MoveAgainst the Nifty 500Times its usual moveVolume, times usualFilings

6 Oct 2026No filing that day or the nextup 9.96%+8.9 pts vs Nifty 5003.1× its usual move · volume 1.4× usual
1 Oct 20261 filingdown 9.71%−8.7 pts vs Nifty 5003.4× its usual move · volume 6.5× usual
30 Sep 20261 filingdown 10.12%−10.0 pts vs Nifty 5003.9× its usual move · volume 11.5× usual
29 Sep 2026No filing that day or the nextdown 11.19%−10.6 pts vs Nifty 5005.1× its usual move · volume 3.9× usual
28 Sep 2026No filing that day or the nextdown 12.76%−11.1 pts vs Nifty 5008.5× its usual move · volume 12.5× usual
17 Sep 20261 filingdown 4.33%−4.9 pts vs Nifty 5003.2× its usual move · volume 2.1× usual
8 May 2026No filing that day or the nextup 12.15%+12.6 pts vs Nifty 5004.4× its usual move · volume 8.4× usual
1 Apr 2026No filing that day or the nextup 10.60%+8.6 pts vs Nifty 5004.3× its usual move · volume 1.0× usual
30 Mar 2026No filing that day or the nextdown 8.83%−6.5 pts vs Nifty 5004.0× its usual move · volume 3.5× usual
22 Dec 2025No filing that day or the nextup 18.01%+17.2 pts vs Nifty 5009.0× its usual move · volume 18.1× usual

20 earlier moves

10 Dec 2025No filing that day or the nextup 10.25%+10.7 pts vs Nifty 5007.6× its usual move · volume 2.0× usual
8 Dec 2025No filing that day or the nextdown 6.02%−4.7 pts vs Nifty 5005.1× its usual move · volume 3.3× usual
3 Sep 2025No filing that day or the nextup 4.24%+3.6 pts vs Nifty 5003.3× its usual move · volume 3.9× usual
20 May 2025No filing that day or the nextup 11.41%+12.6 pts vs Nifty 5003.1× its usual move · volume 27.6× usual
3 Apr 2025No filing that day or the nextup 11.47%+11.6 pts vs Nifty 5002.6× its usual move · volume 2.6× usual
19 Feb 2025No filing that day or the nextup 13.61%+13.0 pts vs Nifty 5002.9× its usual move · volume 1.3× usual
31 Jan 2025No filing that day or the nextup 11.06%+9.7 pts vs Nifty 5002.6× its usual move · volume 2.5× usual
8 Jan 2025No filing that day or the nextdown 11.04%−10.6 pts vs Nifty 5003.2× its usual move · volume 3.0× usual
6 Jan 2025No filing that day or the nextup 19.98%+22.1 pts vs Nifty 5009.4× its usual move · volume 31.0× usual
26 Jul 2024No filing that day or the nextup 7.26%+5.6 pts vs Nifty 5003.3× its usual move · volume 7.2× usual
25 Jul 2024No filing that day or the nextup 7.57%+7.6 pts vs Nifty 5003.8× its usual move · volume 9.5× usual
24 Jul 2024No filing that day or the nextup 7.39%+7.1 pts vs Nifty 5004.3× its usual move · volume 2.7× usual
24 Apr 2024No filing that day or the nextup 12.46%+12.1 pts vs Nifty 5003.6× its usual move · volume 4.5× usual
22 Dec 2023No filing that day or the nextup 19.99%+19.4 pts vs Nifty 5005.1× its usual move · volume 6.6× usual
21 Dec 2023No filing that day or the nextup 14.13%+13.3 pts vs Nifty 5004.1× its usual move · volume 4.5× usual
19 Dec 2023No filing that day or the nextup 19.97%+19.9 pts vs Nifty 5008.9× its usual move · volume 8.6× usual
4 Sep 2023No filing that day or the nextup 8.73%+8.1 pts vs Nifty 5004.4× its usual move · volume 4.1× usual
4 Aug 2023No filing that day or the nextup 7.39%+6.7 pts vs Nifty 5004.2× its usual move · volume 5.0× usual
1 Aug 2023No filing that day or the nextup 11.04%+11.1 pts vs Nifty 50011.4× its usual move · volume 9.9× usual
13 Apr 20231 filingdown 8.68%−8.8 pts vs Nifty 5003.0× its usual move · volume 2.9× usual

Figures filed again

Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.

Line	Period	Accounts	First filed	Filed again		First filed on	Filed again on
Other income	Quarter to Jun 2019	Standalone	1.84	1.84	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Total income	Quarter to Jun 2019	Standalone	8.84	8.84	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Employee costs	Quarter to Jun 2019	Standalone	2.56	2.56	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Other expenses	Quarter to Jun 2019	Standalone	3.14	3.14	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Total expenses	Quarter to Jun 2019	Standalone	13.84	13.84	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Profit before tax	Quarter to Jun 2019	Standalone	−5.00	−5.00	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Tax	Quarter to Jun 2019	Standalone	−1.54	0.97	+162.9%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Net profit	Quarter to Jun 2019	Standalone	−3.46	−5.97	−72.6%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Change in stock held	Quarter to Jun 2019	Standalone	3.80	3.80	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Profit before one-off items and tax	Quarter to Jun 2019	Standalone	−5.00	−5.00	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Deferred tax	Quarter to Jun 2019	Standalone	−1.54	0.97	+162.9%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Net profit from continuing businesses	Quarter to Jun 2019	Standalone	−3.46	−5.97	−72.6%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Total comprehensive income	Quarter to Jun 2019	Standalone	−3.46	−5.97	−72.6%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Segment profit before tax and finance costs	Quarter to Jun 2019	Standalone	−5.00	−5.00	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)
Segment profit before tax	Quarter to Jun 2019	Standalone	−5.00	−5.00	0.0%	10 Aug 2019 (opens in a new tab)	6 Nov 2019 (opens in a new tab)

Last results date

Bharat Immunologicals & Biologicals annual reports, presentations and earnings calls

Annual reports25

Bharat Immunologicals & Biologicals share news and announcements

Sep 2026

Aug 2024

Feb 2024

Dec 2023

Nov 2023

Oct 2023

Sep 2023

May 2023

Apr 2023

Feb 2023

Dec 2022

Oct 2022

Sep 2022

Aug 2022

Jun 2022

May 2022

Apr 2022

Feb 2022

Jan 2022

Dec 2021

Nov 2021

How the price met the news

Sharp moves

Figures filed again